| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $29.7M | $38.0M | $21.1M |
| YoY Revenue Growth % | -21.8% | +80.5% | — |
| Gross Profit | $1.8M | -$23.7M | — |
| Gross Margin % | 6.1% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$33.7M | -$47.5M | -$20.2M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$53.4M | -$63.3M | -$29.2M |
| EBITDA (Normalized) | -$11.2M | -$40.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$9.1M | -$5.1M | -$3.0M |
| Capital Expenditures (CapEx) | $28.1M | $8.9M | — |
| Free Cash Flow (FCF) | -$37.2M | -$13.9M | -$3.0M |
| FCF Margin % | -80.0% | -36.6% | -14.2% |
| Return on Invested Capital (ROIC %) | -37.2% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $17.9M | $7.1M | — |
| Total Stockholders' Equity | $53.5M | -$12.5M | — |